Subscribe for the newsletter
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Gene Therapy
Sort By
Newest First
Sign in
1 / 4
1 / 4
AAV Manufacturing
ProBio Launches GMP AAV Manufacturing Services at Hopewell Facility to Advance Gene Therapy Development and Manufacturing
ProBio Inc
PR-08-25-NI-01
Aug 11, 2025
Gene Therapy
Gene Therapy at a Crossroads: What the Sarepta Crisis Reveals — and What Comes Next
David Alvaro, Ph.D.; April Stanley, MS MBA; Sophie Lutter, Ph.D.
Pharma's Almanac
PAO-08-25-NI-02
Aug 05, 2025
ssDNA
Leveraging the Therapeutic Potential of Single-Stranded DNA
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-07-25-NI-10
Jul 23, 2025
CGT
ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility to Advance Cell and Gene Therapy
ProBio Inc
PR-06-25-NI-11
Jun 30, 2025
AAV
Gene Therapy at a Crossroads: Rethinking AAV Amid Industry Resets
Daniel Smith, Ph.D.
Nice Consulting
PAO-05-25-NI-02
May 06, 2025
Gene Therapy
Gene Therapy at 30: Milestones, Setbacks, and a Path Forward
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-28
Apr 14, 2025
LOGIC GATES
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-03
Mar 14, 2025
Gene Therapy
Genprex Provides Update on Diabetes Gene Therapy Program
Genprex
PR-02-25-NI-15
Feb 19, 2025
Sustainability
Synthetic DNA Delivers a Sustainable Future for Genetic Medicines
Touchlight
PAO-01-25-CL-04
Jan 07, 2025
Nonviral Delivery
Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery using dbDNA
Lisa Caproni
Touchlight
PAO-12-24-CL-4
Dec 16, 2024
Clinical Trials
Beacon Therapeutics Announces Positive 3-Month Data from Phase 2 DAWN Trial in Patients
Beacon Therapeutics
PR-12-24-NI-131
Dec 06, 2024
Gene Therapy
FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
U.S. Food & Drug Administration
PR-11-24-NI-100
Nov 15, 2024
Biotech
Five Small Biotechs to Watch: October 2024
David Alvaro, Ph.D.
Pharma's Almanac
PR-09-24-NI-10
Sep 23, 2024
dbDNA
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
Jill Makin
Touchlight
PAO-08-24-CL-01
Aug 19, 2024
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01
Jul 02, 2024
Digitalization, AI, and Automation
Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds
CRB
PR-M10-23-05
Oct 19, 2023
Plasmid Manufacturing
Optimizing Plasmid Production to Meet Growing Demand
Cynthia A. Challener, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-04-23-NI-01
Apr 03, 2023
AAV Capsid Engineering
Expanding Patient Access to Gene Therapies through AAV Capsid Engineering
Damien Marsic, Ph.D.
Porton Advanced Solutions
PAO-01-23-CL-02-155
Feb 06, 2023
CRISPR Clinical Trial
SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001
SNIPR BIOME
PR-M04-22-11
Apr 20, 2022
Column: M&A
Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game
Nigel Walker
Nice Insight
PAO-03-022-NI-08
Mar 23, 2022